Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial

Cancer Chemotherapy and Pharmacology

Volumn 55, Issue 4, 2005, Pages 387-392

  Matsusaka, Satoshi ^a,b   Nagareda, Tomofumi ^c   Yamasaki, Hajime ^c  

^a National Hospital Organization   (Japan)

^b YAMAGATA UNIVERSITY   (Japan)

^c Takarazuka Municipal Hospital   (Japan)

Author keywords

5 Fluorouracil; Gastric cancer; Inhibition rates of thymidylate synthase

Indexed keywords

CISPLATIN; DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; THYMIDYLATE SYNTHASE;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; LEUKOPENIA; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL SIGNIFICANCE; STOMACH CANCER; THROMBOCYTOPENIA;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG SYNERGISM; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; THYMIDYLATE SYNTHASE;

EID: 15044341145     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-004-0860-8     Document Type: Article

References (27)

1. Sobrero AF, Aschele C, Bertino JR (1997) Fluorouracil in colorectal cancer - a tale of two drugs; implications for biochemical modulation. J Clin Oncol 15(1):368-381
2. Langenbach RJ, Danenberg PV, Heidelberger C (1972) Thymidylate synthase: mechanism of inhibition by 5-fluoro-2′-deoxyuridylate. Biochem Biophys Res Commun 48(6):1565-1571
3. Santi DV, McHenry CS (1972) 5-Fluoro-2′-deoxyuridylate: covalent complex with thymidylate synthase. Proc Natl Acad Sci U S A 69(7):1855-1857
4. Spears CP, Shahinian AH, Moran RG, Heidelberger C, Corbett TH (1982) In vivo kinetics of thymidylate synthase inhibition in 5-fluorouracil-sensitive and -resistant murine colon adenocarcinomas. Cancer Res 42(2):450-456
5. Spears CP, Gustavsson BG, Mitchell MS, Spicer D, Borne M, Bernstein L, Danenberg PV (1984) Thymidylate synthetase inhibition in malignant tumors and normal liver of patients given intravenous 5-fluorouracil. Cancer Res 44(9):4144-4150
6. Parker WB, Cheng YC (1990) Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther 48(3):381-395
7. Takiuchi H, Ajani JA (1998) Uracil-tegafur in gastric carcinoma: a comprehensive review. J Clin Oncol 16(8):2877-2885
8. Wilkinson DS, Pilot HC (1973) Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. J Biol Chem 248(1):63-68
9. Wilkinson DS, Tlsty TD, Hanas RJ (1975) The inhibition of ribosomal RNA synthesis and maturation in Novikoff hepatoma cells by 5-fluorouridine. Cancer Res 35(11):3014-3020
10. Carrico CK, Glazer RI (1979) Effect of 5-fluorouracil on the synthesis and translation of polyadenylic acid-containing RNA from regenerating rat liver. Cancer Res 39(9):3694-3701
11. Spiegelman S, Sawyer R, Nayak R, Ritzi E, Stolfi R, Martin D (1980) Improving the antitumor activity of 5-fluorouracil by increasing its incorporation into RNA via metabolic modulation. Proc Natl Acad Sci U S A 77(8):4966-4970
12. Spears CP, Gustavsson BG, Berne M, Frosing R, Bernstein L, Hayes AA (1988) Mechanism of innate resistance to thymidylate synthase inhibition after 5-fluorouracil. Cancer Res 48(20):5894-5900
13. Okada Y, Anai H, Hattori T, Maehara Y, Nishimura J, Sugimachi K, Nawata H (1991) Cisplatin plus continuous infusion of 5-fluorouracil for 5 days effective for patients with advanced gastric cancer. Anticancer Drugs 2(5):453-456
14. Ohtsu A, Shimada Y, Yoshida S, Saito H, Seki S, Morise K, Kurihara M (1994) Phase II study of protracted infusional 5-fluorouracil combined with cisplatinum for advanced gastric cancer: report from the Japan Clinical Oncology Group (JCOG). Eur J Cancer 30A(14):2091-2093
15. Kondo K, Murase M, Kodera Y, Akiyama S, Ito K, Yokoyama Y, Takagi H, Shirasaka T (1996) Feasibility study on protracted infusional 5-fluorouracil and consecutive low-dose cisplatin for advanced gastric cancer. Oncology 53(1):64-67
16. Chung YS, Yamashita Y, Inoue T, Matsuoka T, Nakata B, Onoda N, Maeda K, Sawada T, Kato Y, Shirasaka T, Sowa M (1997) Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80(1):1-7
17. Kim R, Murakami S, Ohi Y, Inoue H, Yoshida K, Toge T (1999) A phase II trial of low dose administration of 5-fluorouracil and cisplatin in patients with advanced and recurrent gastric cancer. Int J Oncol 15(5):921-926
18. Butour JL, Macquet JP (1977) Differentiation of DNA-platinum complexes by fluorescence. The use of an interesting dye as a probe. Eur J Biochem 78(2):455-463
19. Scanlon KJ, Safirstein RL, Thies H, Gross RB, Waxman S, Guttenplan JB (1983) Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res 43(9):4211-4215
20. Scanlon KJ, Newman EM, Lu Y, Priest DG (1986) Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian cancer cells. Proc Natl Acad Sci U S A 83(23):8923-8925
21. Shirasaka T, Shimamoto Y, Ohshimo H, Saito H, Fukushima M (1993) Metabolic basis of the synergistic activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo. Cancer Chemother Pharmacol 32(3):167-172
22. Etienne MC, Cheradame S, Fischel JL, Formento P, Dassonville O, Renee N, Schneider M, Thyss A, Demard F, Milano G (1995) Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity. J Clin Oncol 13(7):1663-1670
23. Diasio RB, Beavers TL, Carpenter JT (1988) Familial deficiency of dihydropyrimidine dehydrogenase. J Clin Invest 81(1):47-51
24. Masuike T, Kikuchi K, Saito A, Hashimoto T, Takemoto Y (1995) Determination of 5-fluorouracil incorporated into RNA in tissue using gas chromatography-mass spectrometry (in Japanese). Antibiot Chemother 11(7):162-167
25. Dohden K, Ohmura K, Watanabe Y (1993) Ternary complex formation and reduced folate in surgical specimens of human adenocarcinoma tissues. Cancer 71(2):471-480
26. Yamane N, Makino M, Kaibara N (1999) S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells. Cancer 85(2):309-317
27. Nakano H, Namatame K, Suzuki T, Kim J, Sasaki J, Nagasaki H, Makuuchi M, Kumada K (1995) Prognostic evaluation of curatively resected locally advanced gastric cancer patients with preoperative downstaging chemotherapy assessed by histochemical and pharmacologic means. Oncology 52(6):474-482